Search & Filter

Louisiana ranks second on Americans United for Life's 2027 Life List of the most pro-life states in the U.S. and its Attorney General Liz Murrill received the 'Defender of Life' award for challenging Biden-era regulations allowing abortion pills to be distributed by mail.

Democratic candidates Pat Moore and Dan McKay, seeking Louisiana's Fifth District congressional seat, expressed differing views on abortion, with Moore emphasizing pro-life policies and reducing abortions through funding, while McKay opposes a national abortion ban. Moore also supports increasing the wealth cap to protect Social Security, opposing the Republican stance on the issue.

Arkansas has been named the most pro-life state in America for the seventh consecutive year by Americans United for Life, with Louisiana ranking second. Louisiana Attorney General Liz Murrill received Americans United for Life's “Defender of Life” award for her legal efforts against abortion shield laws and defending pro-life state laws.

Candidates for Louisiana’s 5th Congressional District are split on a national abortion ban, with some supporting exceptions for rape and incest while others oppose them, and their views on Medicaid cuts in the One Big Beautiful Bill Act vary. The district, covering 24 parishes in northeast Louisiana, includes rural areas where candidates debate the impact of Medicaid cuts on local hospitals and access to healthcare.

Today, Susan B. Anthony Pro-Life America Candidate Fund announced its endorsement of Julia Letlow for U.S.

Louisiana Attorney General Liz Murrill filed a lawsuit against the FDA challenging the removal of the in-person dispensing requirement for abortion pills, arguing that mailing abortion medication undermines the state's near-total abortion ban. The ongoing legal battle, which includes appeals and a Supreme Court intervention, could significantly impact access to abortion medication for women in Louisiana, where abortion is highly restricted and exceptions are limited.

Live Action founder Lila Rose emphasized that prayer is central to changing hearts and minds in the pro-life movement during the 2026 Life Awards Gala. She highlighted that Louisiana is among the eight states requiring prenatal development education in public schools through Baby Olivia legislation, a key initiative of Live Action.

Louisiana, along with Arkansas and Alabama, filed two lawsuits challenging shield laws in New York, Massachusetts, and California that protect providers of mail-order abortion pills from legal action by states with abortion bans. Louisiana also sued the FDA over its policy allowing telehealth prescribing and mailing of mifepristone, citing safety concerns, as part of broader efforts to enforce its abortion restrictions post-Dobbs.

Louisiana Attorney General Liz Murrill joined Arkansas Attorney General Tim Griffin and 16 other states in filing an amicus brief supporting South Dakota's law restricting the advertising and distribution of abortion pills. The brief urges the Eighth Circuit to reverse a preliminary injunction that blocked enforcement of South Dakota's abortion pill restrictions, defending states' rights to regulate abortion within their borders.

Planned Parenthood Great Plains reports that abortion services make up a significant portion of its operations, with 14,283 abortions out of 38,698 total patients and a strong focus on political advocacy and expanding abortion access, particularly in Kansas, which serves as a regional hub for patients from neighboring pro-life states. Although Louisiana is not part of the Great Plains region, the report raises questions about whether Louisiana should allow abortion organizations or prioritize healthcare providers focused on patient care rather than abortion advocacy.

Planned Parenthood Great Plains reopened its New Orleans clinic after a yearlong closure, providing contraception, STI care, cancer screenings, and gender-affirming care but not abortions due to Louisiana's ban. The reopening comes amid ongoing legal battles over abortion access in Louisiana and aims to address healthcare gaps in the state, with plans to expand telehealth services and potentially increase presence in Baton Rouge.

The Department of Justice informed a U.S. district court in Louisiana that it will not complete its review of the abortion drug mifepristone until mid-December, with findings delayed until at least March 2027, frustrating pro-life groups in the state and beyond.

Planned Parenthood Great Plains will reopen its New Orleans clinic after closing one year ago. Louisiana Right to Life opposes Medicaid funding for Planned Parenthood, citing concerns about abortion referrals to other states and existing local healthcare providers meeting non-abortion needs.

The FDA plans to complete a safety review of the abortion pill mifepristone by March 2027, which could lead to changes in how the drug is prescribed and distributed nationwide. This review is central to a Louisiana legal challenge against federal regulations allowing remote prescription and mail delivery of abortion pills, with the state's Attorney General arguing the FDA did not adequately assess risks before removing in-person dispensing requirements.

Louisiana Attorney General Liz Murrill joined Arkansas and Alabama AGs in suing organizations and individuals who illegally ship abortion drugs by mail, accusing them of endangering women and unborn babies in Louisiana. The lawsuit challenges blue state shield laws and the FDA's removal of in-person dispensing requirements for mifepristone, citing hospitalizations and thousands of unborn deaths in Louisiana linked to these drugs.

The FDA's safety review of mifepristone is expected to be completed by March 2027, according to a court filing in the U.S. District Court for the Western District of Louisiana.

Louisiana Attorney General Liz Murrill and Alliance Defending Freedom have urged the FDA to restore the in-person dispensing requirement for the abortion drug mifepristone, criticizing the agency for delaying its safety study update until March. They argue that the FDA's 2023 decision to remove this requirement has been deemed unlawful by multiple courts and that the delay puts nearly 1,000 unborn babies in Louisiana at risk each month from mail-order abortion drugs.

The FDA announced that its safety review of the abortion pill mifepristone will continue into next year, with a report expected by March 2027 before deciding on any new restrictions. This update was provided in response to a federal judge's order in a lawsuit brought by Louisiana challenging the mail delivery of mifepristone as undermining the state's abortion ban.

Alliance Defending Freedom Of Counsel Erin Hawley commented regarding the U.S. Food and Drug Administration’s court-ordered update submitted Wednesday on its mifepristone safety study. Louisiana Attorney General Liz Murrill and Alliance Defending Freedom attorneys asked the court to require the FDA to restore the in-person dispensing requirement for the abortion drug: “The American people deserve […] The post 90,000 Babies Will be Killed With Abortion Pills Before FDA Finally Does Review appeared first on LifeNews.com .

The LA Illuminator reports on telehealth prescriptions of abortion drugs. The coverage is related to Louisiana as indicated by the source name.

The U.S. Food and Drug Administration said late Wednesday that it expects to complete its long-awaited safety review of abortion pills by mid-December and issue a report evaluating the results by March 2027.

Red states are challenging the legality of mail order abortion pills by taking the issue to the Supreme Court. The outcome could impact abortion access policies in states including Louisiana if similar restrictions are pursued locally.

Planned Parenthood is set to reopen a clinic in New Orleans this month. This marks the return of Planned Parenthood services to the city of New Orleans, Louisiana.

Women in states with post-Dobbs abortion bans, including Louisiana, face a 5.4% increase in annual out-of-pocket health insurance premium costs, with even higher increases for Black and Hispanic women. This rise is linked to insurers passing on costs associated with pregnancy and childbirth complications that have increased due to abortion restrictions in these states.

The 2026 Chauvin Life Chain event is organized by Louisiana Right to Life. This event is connected to pro-life activities in Louisiana.